NASDAQ: NAOV - NanoVibronix, Inc.

Yield per half year: -44%
Dividend yield: 0.00%
Sector: Healthcare

Share chart NanoVibronix, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About NanoVibronix, Inc.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.

more details
The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2017-06-27
ISIN US63008J1088
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nanovibronix.com
Цена ао 3.89
Change price per day: -3.58% (3.91)
Change price per week: -14.12% (4.39)
Change price per month: +5.42% (3.5761)
Change price per 3 month: -40.93% (6.3822)
Change price per half year: -44% (6.732)
Change price per year: +318.89% (0.9)
Change price per 3 year: +314.51% (0.9095)
Change price per 5 year: +35.74% (2.7774)
Change price per year to date: -41.38% (6.4317)
All parameters

Underestimation

Title Value Grade
P/S 0.7896 9
P/BV 0.452 10
P/E 0 0
EV/EBITDA 0.4295 10
Total: 6.13

Efficiency

Title Value Grade
ROA, % -55.6 0
ROE, % -93.05 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0015 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 330.75 10
Yield Ebitda, % -38.66 0
Yield EPS, % -87.3 0
Total: 2
More

Institutions Volume Share, %
Renaissance Technologies, LLC 41200 1.48
Vanguard Group Inc 30194 1.08
Geode Capital Management, LLC 14461 0.52
Amtrust Financial Services, Inc. 12408 0.45
Tower Research Capital LLC (TRC) 5262 0.19
UBS Group AG 3537 0.13
National Bank of Canada/FI 110 0
Blackrock Inc. 74 0
Wells Fargo & Company 13 0
Morgan Stanley 10 0



Head Job title Payment Year of birth
Mr. Brian M. Murphy CEO & Director 382.5k 1957 (68 years)
Mr. Stephen R. Brown CPA Chief Financial Officer 292.5k 1956 (69 years)
Dr. Harold Jacob M.D. Chief Medical Officer & Director N/A 1954 (71 year)
Mr. Amir Rippel Vice President of Marketing N/A
Ms. Lindsey Harrison Vice President of Sales N/A

Address: United States, Elmsford. NY, 525 Executive Boulevard - open in Google maps, open in Yandex maps
Website: https://www.nanovibronix.com